Anderson, DW and Schaefer, EJ and Bronzert, TJ and Lindgren, FT and Forte, T and Starzl, TE and Niblack, GD and Zech, LA and Brewer, HB
(1981)
Transport of apolipoproteins A-I and A-II by human thoracic duct lymph.
Journal of Clinical Investigation, 67 (3).
857 - 866.
ISSN 0021-9738
Abstract
The daily transport of human plasma apolipoproteins A-I and A-II, triglyceride, and total cholesterol from the thoracic duct lymph into plasma was measured in 2 subjects before and 3 subjects after renal transplantation. Lymph triglyceride transport was ~83% of the daily ingested fat loads, whereas lymph cholesterol transport was consistently greater than the amount of daily ingested cholesterol. Lymph apolipoprotein transport significantly (P < 0.05) exceeded the predicted apolipoprotein synthesis rate by an average of 659±578 mg/d for apolipoprotein A-I and 109±59 mg/d for apolipoprotein A-II among the 5 subjects. It is estimated that 22-77% (apolipoprotein A-I) and 28-82% (apolipoprotein A-II) of daily total body apolipoprotein synthesis takes place in the intestine. Lymph high density lipoprotein particles are mostly high density lipoprotein(2b) and high density lipoprotein(2a) and have a greater overall relative triglyceride content and a smaller relative cholesteryl ester content when compared with homologous plasma high density lipoproteins. The major quantity of both lymph apolipoprotein A-I (81±8%) and apolipoprotein A-II (90±11%) was found within high density lipoproteins with almost all of the remainder found in chylomicrons and very low density lipoproteins. The combined results are consistent with a major contribution of the intestine to total body synthesis of apolipoprotein A-I and apolipoprotein A-II. An important role of lymph in returning filtered apolipoprotein to plasma in association with high density lipoproteins is proposed. Accompanying the return of filtered apolipoprotein to the plasma is a probable transformation, both in size and composition, of at least some of the lymph high density lipoprotein(2b) and high density lipoprotein(2a) particles into high density lipoprotein3.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID |
---|
Anderson, DW | | | | Schaefer, EJ | | | | Bronzert, TJ | | | | Lindgren, FT | | | | Forte, T | | | | Starzl, TE | tes11@pitt.edu | TES11 | | Niblack, GD | | | | Zech, LA | | | | Brewer, HB | | | |
|
Centers: |
Other Centers, Institutes, Offices, or Units > Thomas E. Starzl Transplantation Institute |
Date: |
1 January 1981 |
Date Type: |
Publication |
Journal or Publication Title: |
Journal of Clinical Investigation |
Volume: |
67 |
Number: |
3 |
Page Range: |
857 - 866 |
DOI or Unique Handle: |
10.1172/jci110103 |
Institution: |
University of Pittsburgh |
Refereed: |
Yes |
ISSN: |
0021-9738 |
Other ID: |
uls-drl:31735062114313, Starzl CV No. 465 |
Date Deposited: |
08 Apr 2010 17:07 |
Last Modified: |
22 Jun 2021 10:55 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/3851 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
|
View Item |